72842 Federal Register / Vol. 70, No. 234 / Wednesday, December 7, 2005 / Notices 

availability. Additional information on 

the existing methodology used in the 

development of the CERCLA Priority 

List of Hazardous Substances can be 

found in the Support Document to the 

List and in the Federal Register notices 

mentioned above. 

In addition to the revised priority list, 

ATSDR is also releasing a Completed 

Exposure Pathway Site Count Report. A 

completed exposure pathway (CEP) is 

an exposure pathway that links a 

contaminant source to a receptor 

population. The CEP ranking is very 

similar to a sub-component of the 

potential-for-human-exposure 

component of the listing algorithm. The 

CEP ranking is based on a site frequency 

count, and thus lists the number of sites 

at which a substance has been found in 

a CEP. ATSDR’s HazDat database 

contains this information which is 

derived from ATSDR public health 

assessments and health consultations. 

Because exposure to hazardous 

substances is of significant concern, 

ATSDR is publishing this CEP report 

along with the CERCLA Priority List of 

Hazardous Substances. Since this CEP 

report focuses on documented exposure, 

it provides an important prioritization 

based on substances to which people are 

exposed. 

The substances on the CEP report are 

similar to the substances on the 

CERCLA Priority List of Hazardous 

Substances. However, there are some 

substances that are on the CEP report 

because they are frequently found in 

completed exposure pathways, but are 

not on the CERCLA Priority List because 

they have a very low toxicity (e.g., 

sodium). Since the CERCLA Priority List 

incorporates three different components 

(toxicity, frequency of occurrence, and 

potential for human exposure) to 

determine its priority substances, 

substances with very low toxicity are 

not on the CERCLA Priority List and 

consequently are not the subject of 

toxicological profiles. In addition, since 

the Priority List is mandated by 

CERCLA, it only uses data from sites on 

the CERCLA National Priorities List, 

whereas the CEP report uses data from 

all sites with ATSDR activities that have 

a CEP. Of the 100 substances on the CEP 

report, the 25 substances found at the 

most number of sites in a CEP are 

presented below. 

Substance name 

Number of 

sites with 

substance in 

a CEP 

All 

sites 

NPL 

sites 

Lead ...................................... 431 267 

Substance name 

Number of 

sites with 

substance in 

a CEP 

All 

sites 

NPL 

sites 

Trichloroethylene .................. 363 286 

Arsenic .................................. 341 208 

Tetrachloroethylene .............. 280 207 

Benzene ................................ 210 137 

Cadmium .............................. 207 136 

Volatile Organic Compounds, 

Unspecified ....................... 193 132 

Chromium ............................. 193 129 

Polychlorinated Biphenyls .... 177 116 

Mercury ................................. 167 93 

Manganese ........................... 164 95 

Zinc ....................................... 158 95 

Copper .................................. 143 83 

1,1,1-Trichloroethane ............ 135 110 

Chloroform ............................ 124 92 

Benzo(A)Pyrene ................... 122 58 

1,1-Dichloroethene ............... 117 96 

Polycyclic Aromatic Hydrocarbons ............................. 117 79 

Nickel .................................... 112 70 

Methylene Chloride ............... 111 73 

Toluene ................................. 111 68 

Antimony ............................... 108 69 

Vinyl Chloride ....................... 103 84 

Barium .................................. 102 56 

1,2-Dichloroethane ............... 96 77 

Note: Sorted by the All Sites column. 

All Sites = all sites with ATSDR activities 

that have a CEP; NPL. 

Sites = current and former sites on the National Priorities List, as mandated. 

Dated: November 29, 2005. 

Ken Rose, 

Acting Director, Office of Policy, Planning 

and Evaluation, National Center for 

Environmental Health/Agency for Toxic 

Substances and Disease Registry. 

[FR Doc. E5–6971 Filed 12–6–05; 8:45 am] 

BILLING CODE 4163–70–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Statement of Organization, Functions, 

and Delegations of Authority 

Part C (Centers for Disease Control 

and Prevention) of the Statement of 

Organization, Functions, and 

Delegations of Authority of the 

Department of Health and Human 

Services (45 FR 67772–76, dated 

October 14, 1980, and corrected at 45 FR 

69296, October 20, 1980, as amended 

most recently at 70 FR 70617–18, dated 

November 22, 2005) is amended to 

reflect the reorganization of the 

Facilities Planning and Management 

Office, within the Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention. 

Section C–B, Organization and 

Functions, is hereby amended as 

follows: 

Delete in its entirety the titles and 

functional statements for the Facilities 

Planning and Management Office 

(CAJ3) and insert the following: 

Buildings and Facilities Office (CAJC). 

(1) Operates, maintains, repairs, and 

modifies CDC’s Atlanta area plant 

facilities, and conducts a maintenance 

and repair program for CDC’s program 

support equipment; (2) carries out 

facilities planning functions for CDC, 

including new or expanded facilities, 

and a major repair and improvement 

program; (3) develops services for new, 

improved, and modified equipment to 

meet program needs, i.e., building 

related and installed equipment such as 

HVAC, bio safety cabinets, chemical 

fume hoods, walk-in freezers, etc; and 

(4) conducts CDC’s real property and 

space management activities, including 

the acquisition of leased space, the 

purchase and disposal of real property, 

and provides technical assistance in 

space planning to meet programmatic 

needs. 

Office of the Director (CAJC1). (1) 

Plans, directs, and coordinates the 

functions and activities of the Buildings 

and Facilities Office (BFO); (2) provides 

management and administrative 

direction for budget planning and 

execution, property management, and 

personnel management within BFO; (3) 

provides leadership and strategic 

support to senior managers in the 

determination of CDC’s long-term 

facilities needs; (4) coordinates the 

operations of BFO staff involved in the 

planning, evaluation, design, 

construction, and management of 

facilities and acquisition of property; (5) 

provides centralized value engineering 

(VE) services, policy development and 

coordination, and global acquisition 

planning for BFO; (6) develops and 

maintains the Integrated Facilities 

Management System to process data for 

management and control systems, and 

develop reports and analyses; and (7) 

assists and advises senior CDC officials 

in the development, coordination, 

direction, and assessment of facilities 

and real property activities throughout 

CDC’s facilities and operations, and 

assures consideration of facilities 

management implications in program 

decisions. 

Capital Improvements Management 

Office (CAJCB). (1) Provides 

professional architectural/engineering 

capabilities, and technical and 

administrative project support to CDC 

and the national centers (NC) for 

renovations and improvements to CDCowned facilities and construction of 

Federal Register / Vol. 70, No. 234 / Wednesday, December 7, 2005 / Notices 72843 

new facilities; (2) develops project 

management requirements (including 

determination of methods, means of 

project completion, and selection of 

resources); (3) provides critical path 

method scheduling support for all large 

capital construction projects and all 

repair and improvements (R&I) projects; 

and (4) provides central cost estimating 

support for all large capital construction 

projects, all R&I projects, special 

projects, feasibility studies, as 

requested, and certain work orders, as 

requested. 

Design Engineering Management 

Office (CAJCC). (1) Prepares 

architectural and engineering designs, 

and specifications for construction of 

modifications and renovations to CDCowned facilities; (2) provides 

architectural and engineering technical 

expertise and is the technical authority 

on new facilities, and modifications and 

renovations on facility project designs; 

(3) provides furniture, fixture, and 

equipment designs, and project 

management services for all CDC 

facilities; (4) provides record and 

guideline document support services to 

all BFO offices; and (5) maintains CDC 

Design Standards and Guidelines for use 

as basis of design for construction of 

new facilities, and modifications and 

renovations in CDC-owned facilities. 

Facilities Maintenance & Engineering 

Office (CAJCD). (1) Operates, maintains, 

repairs, and modifies CDC’s Atlanta area 

plant facilities and other designated 

CDC facilities throughout the United 

States (US) and Puerto Rico (PR), and 

conducts a maintenance and repair 

program for CDC’s program support 

equipment; (2) develops services for 

new, improved, and modified 

equipment to meet program needs; (3) 

provides technical assistance, reviews 

maintenance and operation programs, 

and recommends appropriate action for 

all Atlanta area facilities and other 

designated CDC facilities throughout the 

US and PR; (4) provides 

recommendations, priorities, and 

services for new, improved, or modified 

equipment to meet program needs; (5) 

provides maintenance and operation of 

the central energy plant including 

structures, utilities production and 

distribution systems, and equipment; (6) 

conducts a program of custodial 

services, waste disposal, incinerations, 

disposal of biological waste, and other 

building services at all CDC Atlanta area 

facilities and other designated CDC 

facilities throughout the US and PR; (7) 

provides landscape development, 

repair, and maintenance at all CDC 

Atlanta area facilities and other 

designated CDC facilities throughout the 

US and PR; (8) provides hauling and 

moving services for CDC in the Atlanta 

area; (9) provides an Integrated Pest 

Management Program to control insect 

and rodents for CDC in Atlanta area 

facilities; (10) develops required 

contractual services and provides 

supervision for work performed in these 

areas; (11) establishes and maintains a 

computerized system for maintenance 

services, for stocking and ordering 

supplies, and replacement parts; (12) 

provides for pick-up and delivery of 

supplies and replacement parts; to work 

sites; (13) maintains adequate stock 

levels of supplies and replacement 

parts; (14) as needed, prepares designs 

and contract specifications, and 

coordinates completion of contract 

maintenance projects; (15) manages 

CDC’s Energy Conservation Program for 

all CDC facilities; (16) reviews all 

construction documents for energy 

conservation goals and compliance with 

applicable CDC construction standards; 

(17) participates on all core teams and 

VE teams; (18) provides maintenance 

and inspection for fire extinguishers and 

fire sprinkler systems; (19) provides 

services for the procurement of natural 

gas; (20) develops and maintains a 

standard equipment list for all CDC 

facilities; (21) assists the Design 

Engineering Management Office and the 

Capital Improvements Management 

Office with facility-related issues; (22) 

provides building coordinators to 

interface with program personnel and 

all work to keep the building and 

equipment functioning; and (23) 

responsible for new building 

commissioning. 

Real Property Management Office 

(CAJCE). (1) Conducts the real estate 

activities throughout CDC, including the 

acquisition of leased space, the 

purchase and disposal of real property 

for CDC nationwide (with emphasis on 

current and long-range planning for 

utilization of existing and future real 

property resources); (2) responsible for 

space assignment and utilization of all 

CDC space, both owned and leased, 

nationwide; (3) provides technical 

assistance in space planning to meet 

programmatic needs; (4) responsible for 

executing all easements for owned 

property; (5) administers day-to-day 

management of leased facilities and 

ensures contract compliance by lessors; 

(6) provides technical assistance and 

prepares contract specifications for all 

repair and improvement projects in 

leased space; (7) maintains liaison with 

the General Services Administration 

Regional Offices; (8) performs all 

functions relating to leasing and/or 

acquisition of real property under CDC 

delegation of authority for leasing, 

including direct lease actions; and (9) 

coordinates the relocation of CDC 

personnel within owned and leased 

space. 

Dated: November 28, 2005. 

William H. Gimson, 

Chief Operating Officer, Centers for Disease 

Control and Prevention (CDC). 

[FR Doc. 05–23689 Filed 12–6–05; 8:45 am] 

BILLING CODE 4160–18–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. 2004N–0535] 

Agency Information Collection 

Activities; Announcement of Office of 

Management and Budget Approval; 

MedWatch: Food and Drug 

Administration Medical Products 

Reporting Program 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing 

that a collection of information entitled 

‘‘MedWatch: Food and Drug 

Administration Medical Products 

Reporting Program’’ has been approved 

by the Office of Management and 

Budget (OMB) under the Paperwork 

Reduction Act of 1995. 

FOR FURTHER INFORMATION CONTACT: 

Karen Nelson, Office of Management 

Programs (HFA–250), Food and Drug 

Administration, 5600 Fishers Lane, 

Rockville, MD 20857, 301–827–1482. 

SUPPLEMENTARY INFORMATION: In the 

Federal Register of December 27, 2004 

(69 FR 77256), the agency announced 

that the proposed information collection 

had been submitted to OMB for review 

and clearance under 44 U.S.C. 3507. An 

agency may not conduct or sponsor, and 

a person is not required to respond to, 

a collection of information unless it 

displays a currently valid OMB control 

number. OMB has now approved the 

information collection and has assigned 

OMB control number 0910–0291. 

As requested by the agency, in 

addition to the approval of the revised 

forms, the existing forms are approved 

for continued use for the next 12 

months to allow for the industry to 

make necessary changes to their 

computerized systems. 

The approval expires on October 31, 

2008. A copy of the supporting 

statement for this information collection 

is available on the Internet at http:// 

www.fda.gov/ohrms/dockets.